Commure vs GenHealth.ai
Two RCM Automation Platforms vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Commure | GenHealth.ai | |
|---|---|---|
| Pricing model | Enterprise contract (custom) · Custom deals across a broad product suite | Usage-based · Per workflow, plus actions run each month |
| Speed to go live | Deep EHR and RCM integration for full suite | Browser agents, no EHR integration project |
| Automation model | Software platform · Ambient AI plus RCM automation suite | Autonomous agents · AI agents execute RCM workflows |
| Built for | Mid-size groups, Enterprise systems | Small practices, Mid-size groups, Payers |
| Security posture | SOC 2 Type II, HIPAA | SOC 2 Type II, HIPAA |
| Company maturity | 9 yrs (est. 2017) | 3 yrs (est. 2023) |
| Financial backing | $1B+ · Late-stage private, $7B valuation (2026) | $13M · Seed |
| Named customers | 4 named | 5 named |
| Published results | No public numbers | Specific numbers public |
| Documented integrations | 4 listed | EHR-agnostic |
| Third-party validation | None found | KLAS / analyst cited |
Bottom line
- Pick Commure if you're an enterprise health system that wants ambient documentation and revenue cycle automation consolidated under one vendor.
- Pick GenHealth.ai if you want prior auth, eligibility, claims automation, or other custom work done by autonomous agents in your existing systems within weeks, without an integration project.
Commure
AI platform for clinical documentation and revenue cycle work
- Founded
- 2017
- HQ
- San Francisco, CA
- Stage
- Late-stage private, $7B valuation (2026)
- Raised
- $1B+
What it does
- Ambient AI clinical documentation (scribing)
- Revenue cycle automation across front, middle, and back office
- Practice management and billing for medical groups
- Clinician workflow tools (PatientKeeper lineage)
- Staff duress and safety badges (Strongline)
- Patient engagement and care management (Memora)
Where it's strong
- Deep General Catalyst backing and health system relationships give it staying power and large reference customers like HCA.
- Breadth is unusual: one contract can cover ambient documentation, RCM automation, and practice management.
- Claims deployment across 130+ health systems and 3,000+ sites, so it has real enterprise scale.
What buyers should weigh
- The platform is an assembly of acquired products (Athelas, PatientKeeper, Augmedix, Memora), so integration depth varies by module.
- Fast growth by M&A means product roadmaps and account teams can shift; ask which products are strategic.
- Its marquee metrics (85%+ touchless RCM work) are vendor-reported and worth validating in a pilot.
Named customers
HCA Healthcare · Tenet Healthcare · Jefferson Health · Providence
Integrations
GenHealth.ai
An agentic OS for healthcare administration
- Founded
- 2023
- HQ
- San Francisco, CA
- Stage
- Seed
- Raised
- $13M
What it does
- Reads faxed and emailed orders and enters intake data into the EMR
- Verifies eligibility and benefits before orders move forward
- Drafts and submits prior authorizations matched to payer policy
- Checks clinical documentation against payer criteria and flags gaps
- Files claims and works denials and collections
- Automates resupply programs and utilization management review
Where it's strong
- Publishes customer results with real numbers: Piedmont Medical Solutions reported a 34.2% increase in paid-to-date collections, and Guidehealth reported $1.2M in annual savings.
- Multimodal by design: direct integrations with Epic, eClinicalWorks, athenahealth, and Brightree, plus browser agents that log in and work any portal, fax queue, or phone tree without an API.
- Founded by the team behind interoperability company 1upHealth, with backing from Craft Ventures and Obvious Ventures and advisors including Aneesh Chopra and Don Rucker.
- Named in multiple Gartner Hype Cycle reports, including Healthcare Data, Analytics and AI (2024), Generative AI (2024), and US Healthcare Payers (2025), rare analyst visibility for a seed-stage company.
What buyers should weigh
- Founded in 2023 and still at seed stage, so it is a young vendor compared with established RCM and prior auth incumbents.
- Public case studies concentrate in DME/HME and MSO utilization management; evidence in other care settings is thinner.
- No new funding round has been publicly announced since the July 2023 seed, so buyers should ask about company scale and support capacity.
Named customers
Piedmont Medical Solutions · Guidehealth · MedExpress · Soundview Medical · Spectrum Medical
Integrations
Compare against the rest of RCM Automation Platforms
Deciding between these two?
First Pass tracks RCM Automation Platforms every week: funding, launches, and what changed since this page was written.